This article discusses two studies looking into agricultural biotechnology research in developing countries. The studies were conducted by researchers from the International Food Policy Research Institute.

The authors argue that regulations, insufficient collaboration between public and private sectors and inadequate information exchange between countries impede the commercial development of new agri-biotechnologies, particularly for genetically modified crops. The paper explores these problems and makes a set of recommendations.

The authors' conclusions may not persuade all readers. For example, are the regulatory frameworks themselves at fault, or do public sector research organisations lack the capacity to carry out necessary risk assessments and safety testing? Only 55 per cent of public sector research targets crops that are considered critical to poverty eradication and food security. This article provides a thought-provoking contribution to the debate.


Related topics